another PD trial by bayer
First participants randomized in AskBio P... - Cure Parkinson's
First participants randomized in AskBio Phase II gene therapy trial for Parkinson’s disease
Written by
Farooqji
To view profiles and participate in discussions please or .
Read more about...
1 Reply
•
This one looks very promising for at least a moderate protection effect
Not what you're looking for?
You may also like...
Annovis Bio Announces First Patient Dosed in Phase 3 Trial in Patients with Early Parkinson’s Disease
Annovis Bio Announces First Patient Dosed in Phase 3 Trial in Patients with Early Parkinson’s...
Photopharmics kickstarts phototherapy trial for Parkinson’s disease
The US Food and Drug Administration (FDA)-approved device targets photoreceptors in the eye...
Potential disease-modifying therapy enters Phase 2
"Following the review of the data of the 101 trial, the drug advanced to the Phase II 201 trial...
Randomized Trial of Focused Ultrasound Subthalamotomy for Parkinson’s Disease
TAmong 40 enrolled patients, 27 were assigned to focused ultrasound subthalamotomy (active...
Australian trial gives new hope for Parkinson’s disease treatment
There’s quiet but confident hope for a breakthrough treatment for Parkinson’s disease, following a...
Related Posts
Phase 3 trial of buntanetap for early-stage Parkinson’s nears end
Drug fails in Phase II trial for treating Parkinson's Disease - Exenatide (Byetta, Bydureon)- MRI-Focused Ultrasound Undergoing Phase 3 Clinical Trial for Parkinson’s Treatment
Cure Parkinson’s and Van Andel Institute announce funding for a phase 1 clinical trial of low-dose lithium in Parkinson’s disease
Hot off the press. Randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson’s disease.
